A prospective, open-label, one arm study to evaluate the safety and efficacy of Efatop HYDRA GEL for its noncomedogenic effect in healthy male or female volunteers. - Non-comedogenic

ERIS LIFESCIENCES LTD.0 个研究点目标入组 20 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•1.Healthy Indian male/female healthy volunteers aged between 18-55 years.
•2.Willing to give Informed Consent Form.
•3.Subjects with Clear to mild skin condition according to GAGS score 0 to 2.
•4.Willing to complete the study assessments/questionnaires.
•5.Willing to avoid usage of his/her own skin care products for at least one week before Commencement and during this study.

•1.Pregnancy or breast feeding.
•2.Patients with pre-existing severe systemic disease necessitating long-term medication.
•3.Patients with mild to severe Anaphylaxis reactions.
•4.Evidence of significant uncontrolled co-morbid disease.
•5.Historyofcancer,includingsolidtumours,hematologic malignancies and carcinoma in situ
•6.Any neurological (congenital or acquired), vascular or systemic disorder which could affect any of the efficacy assessments.
•7.Participation in the current or previous clinical trial with any approved or investigational products during the past 1 month.

发起方

ERIS LIFESCIENCES LTD.